APA (7th ed.) Citation

Sun, J., Sun, X., He, W., Huang, B., Feng, W., Han, Z., . . . Zhou, X. (2025). A liquid biopsy approach detects HCC and identifies GJA4 as a potential biomarker for HBV-HCC via plasma cfDNA methylome profiling. Clinical Epigenetics, 17(1), 1. https://doi.org/10.1186/s13148-025-01909-w

Chicago Style (17th ed.) Citation

Sun, Jialing, et al. "A Liquid Biopsy Approach Detects HCC and Identifies GJA4 as a Potential Biomarker for HBV-HCC via Plasma CfDNA Methylome Profiling." Clinical Epigenetics 17, no. 1 (2025): 1. https://doi.org/10.1186/s13148-025-01909-w.

MLA (9th ed.) Citation

Sun, Jialing, et al. "A Liquid Biopsy Approach Detects HCC and Identifies GJA4 as a Potential Biomarker for HBV-HCC via Plasma CfDNA Methylome Profiling." Clinical Epigenetics, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13148-025-01909-w.